MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Stability Notes

Store in airtight containers. Protect from light and moisture.

Provenance

This compatibility recommendation is derived from Galsya XL 24mg capsules (Krka UK Ltd) and Reminyl XL 24mg capsules (Takeda UK Ltd).

Stability Notes

Store in airtight containers. Protect from light and moisture.

Provenance

This compatibility recommendation is derived from Galsya XL 24mg capsules (Krka UK Ltd) and Reminyl XL 24mg capsules (Takeda UK Ltd).

Stability Notes

Store in airtight containers. Protect from light and moisture.

Provenance

This compatibility recommendation is derived from Galsya XL 8mg capsules (Krka UK Ltd) and Reminyl XL 8mg capsules (Takeda UK Ltd).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Renacet 475mg tablets (Stanningley Pharma Ltd).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Renacet 950mg tablets (Stanningley Pharma Ltd).

Stability Notes

Store in an airtight container and protect from moisture.

Provenance

This compatibility recommendation is derived from Renagel 800mg tablets (Sanofi) and Renvela 800mg tablets (Sanofi).

Stability Notes

Store in an airtight container and protect from moisture.

Provenance

This compatibility recommendation is derived from Renagel 800mg tablets (Sanofi) and Renvela 800mg tablets (Sanofi).

Stability Notes

Store in an airtight container and protect from moisture.

Provenance

This compatibility recommendation is derived from Renagel 800mg tablets (Sanofi) and Renvela 800mg tablets (Sanofi).

Print this list

Medicines under this category are suitable for use inside MCAs, although this is likely to be an off-label use.
Medicines under this category can theoretically be used inside an MCA; however, mitigations may need to be considered.
Medicines under this category are not suitable for use inside MCAs.
We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.